Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans
Journal of Nuclear Medicine · 2023-12 · 64 (12) · 1895-1898
DOI: 10.2967/jnumed.123.266185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 05.10.2023. Verfasst von Taymeyah Al-Toubah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Carcinoma, Neuroendocrine, Organometallic Compounds. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Somatostatin receptor (SSTR) expression in metastatic lung neuroendocrine tumors (NETs) has not been well characterized using PET imaging. Understanding the degree and uniformity of SSTR expression is important to establish the role of SSTR-targeted treatments in lung NETs.
Methods
A retrospective institutional review of patients with metastatic lung NETs who underwent DOTATATE PET imaging from March 2017 to February 2023 was performed.
Results
In total, 48 patients with metastatic lung NETs who underwent 68Ga- or 64Cu-DOTATATE PET imaging were identified. Four had completely negative SSTR expression, and 10 had very weak expression (less than in a normal liver). Among the remaining 34 patients, 21 had uniformly positive DOTATATE PET scans, and 13 had heterogeneous expression. Only 44% had uniformly positive receptor expression, identifying them as candidates for peptide receptor radionuclide therapy.
Conclusion
Most metastatic lung NETs lack uniform SSTR expression and are thus suboptimal candidates for SSTR-targeted therapy. SSTR imaging in lung NETs should be evaluated carefully for uniformity of expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and.
- Department of Diagnostic Imaging, Nuclear Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and jonathan.strosberg@moffitt.org.
Zitieren
APA
Al-Toubah, T., Montilla-Soler, J., El-Haddad, G., Haider, M., & Strosberg, J. (2023). Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans. Journal of Nuclear Medicine, 64(12), 1895-1898. https://doi.org/10.2967/jnumed.123.266185
Vancouver
Al-Toubah T, Montilla-Soler J, El-Haddad G, Haider M, Strosberg J. Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans. Journal of Nuclear Medicine. 2023;64(12):1895-1898. doi:10.2967/jnumed.123.266185
BibTeX
@article{AlToubah2023,
author = {Al-Toubah, Taymeyah and Montilla-Soler, Jaime and El-Haddad, Ghassan and Haider, Mintallah and Strosberg, Jonathan},
title = {Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans},
journal = {Journal of Nuclear Medicine},
year = {2023},
volume = {64},
number = {12},
pages = {1895--1898},
doi = {10.2967/jnumed.123.266185}
}
EUVIMED